Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 34% ± 14% | |
brain | 17 studies | 30% ± 16% | |
lung | 9 studies | 28% ± 9% | |
eye | 7 studies | 27% ± 11% | |
heart | 5 studies | 18% ± 2% | |
intestine | 5 studies | 20% ± 3% | |
kidney | 4 studies | 20% ± 2% | |
bone marrow | 4 studies | 24% ± 5% | |
uterus | 4 studies | 27% ± 9% | |
liver | 4 studies | 25% ± 7% | |
adipose | 4 studies | 23% ± 3% | |
lymph node | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 6375.80 | 2642 / 2642 | 100% | 57.30 | 705 / 705 |
esophagus | 100% | 6630.18 | 1445 / 1445 | 100% | 40.95 | 183 / 183 |
lung | 100% | 6282.02 | 578 / 578 | 100% | 45.85 | 1155 / 1155 |
prostate | 100% | 6296.94 | 245 / 245 | 100% | 52.74 | 502 / 502 |
breast | 100% | 6222.09 | 459 / 459 | 100% | 61.49 | 1117 / 1118 |
bladder | 100% | 6598.76 | 21 / 21 | 100% | 35.70 | 503 / 504 |
thymus | 100% | 6094.38 | 653 / 653 | 100% | 48.79 | 603 / 605 |
uterus | 100% | 7161.61 | 170 / 170 | 100% | 35.77 | 457 / 459 |
ovary | 100% | 8602.53 | 180 / 180 | 100% | 29.88 | 428 / 430 |
pancreas | 100% | 3827.32 | 328 / 328 | 99% | 38.20 | 177 / 178 |
stomach | 100% | 4519.81 | 359 / 359 | 99% | 36.07 | 283 / 286 |
kidney | 100% | 3879.81 | 89 / 89 | 99% | 38.77 | 891 / 901 |
intestine | 100% | 6861.51 | 966 / 966 | 98% | 33.90 | 518 / 527 |
skin | 100% | 7296.81 | 1809 / 1809 | 97% | 39.42 | 458 / 472 |
adrenal gland | 100% | 5033.80 | 258 / 258 | 97% | 34.61 | 223 / 230 |
liver | 100% | 2519.67 | 226 / 226 | 92% | 18.41 | 373 / 406 |
blood vessel | 100% | 6387.47 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 54.12 | 29 / 29 |
muscle | 100% | 5871.60 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7327.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.40 | 1 / 1 |
adipose | 100% | 6193.23 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 6510.68 | 913 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 4767.59 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 40.31 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034063 | Biological process | stress granule assembly |
GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
GO_0033962 | Biological process | P-body assembly |
GO_0030182 | Biological process | neuron differentiation |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0019074 | Biological process | viral RNA genome packaging |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0017148 | Biological process | negative regulation of translation |
GO_0016020 | Cellular component | membrane |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0016442 | Cellular component | RISC complex |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0004386 | Molecular function | helicase activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | DDX6 |
Protein name | Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK) |
Synonyms | HLR2 RCK |
Description | FUNCTION: Essential for the formation of P-bodies, cytosolic membrane-less ribonucleoprotein granules involved in RNA metabolism through the coordinated storage of mRNAs encoding regulatory functions . Plays a role in P-bodies to coordinate the storage of translationally inactive mRNAs in the cytoplasm and prevent their degradation . In the process of mRNA degradation, plays a role in mRNA decapping . Blocks autophagy in nutrient-rich conditions by repressing the expression of ATG-related genes through degradation of their transcripts . . |
Accessions | ENST00000620157.4 ENST00000526070.2 P26196 ENST00000534980.7 |